The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis

Photodynamic therapy (PDT) is a treatment for cancer and pre-malignant conditions, which involves the administration of a photosensitising agent followed by exposure of the tissue to light. 5-Aminolaevulinic acid (ALA) is a naturally occurring compound in the haem biosynthetic pathway, which is metabolised to a photosensitive product, protoporphyrin IX (PpIX). The major advantage of ALA when compared to synthetic photosensitisers is the rapid metabolism, which significantly reduces the period of cutaneous photosensitivity. This review focuses on the development of ALA as a photosensitiser in photodynamic therapy and photodiagnosis, and the wide range of clinical applications in which ALA is now being used as a therapeutic modality.

[1]  C. Rimington.  Porphyrin and haem biosynthesis and its control. , 2009, Acta medica Scandinavica. Supplementum.

[2]  M. Goldman,et al.  ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy , 2003, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[3]  Peter D Siersema,et al.  Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus. , 2002, Journal of photochemistry and photobiology. B, Biology.

[4]  H Stepp,et al.  Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.

[5]  C. Whitehurst,et al.  Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.

[6]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: long‐term follow‐up , 2001 .

[7]  P. Devitt,et al.  Laparoscopic Nissen versus anterior fundoplication in patients with oesophageal dysmotility: a randomized controlled trial , 2001 .

[8]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[9]  D. Ladner,et al.  Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid , 2001, British Journal of Cancer.

[10]  A. Curnow,et al.  Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. , 2000, Journal of photochemistry and photobiology. B, Biology.

[11]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.

[12]  C. Whitehurst,et al.  Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.

[13]  R. Anderson,et al.  Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.

[14]  S. Tajima,et al.  Topical δ‐Aminolevulinic Acid‐Based Photodynamic Therapy for Japanese Actinic Keratoses , 2000 .

[15]  J Moan,et al.  Phototransformations of 5-Aminolevulinic Acid–induced Protoporphyrin IX in vitro: A Spectroscopic Study¶ , 2000, Photochemistry and photobiology.

[16]  H Stepp,et al.  Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. , 2000, American journal of obstetrics and gynecology.

[17]  J. Moan,et al.  Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5-Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000, Photochemistry and photobiology.

[18]  H Stepp,et al.  Photodetection of cervical intraepithelial neoplasia using 5‐aminolevulinic acid–induced porphyrin fluorescence , 2000, Cancer.

[19]  U. Pichlmeier,et al.  No Generalized Skin Phototoxicity after Intravesical Application of 5-Aminolevulinic Acid for Fluorescence Diagnosis ofSuperficial Bladder Cancer , 2000, Urologia Internationalis.

[20]  R Jakobs,et al.  Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. , 2000, Gastrointestinal endoscopy.

[21]  Christian Gluud,et al.  Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.

[22]  H Stepp,et al.  Photodynamic therapy of vulvar intraepithelial neoplasia using 5‐aminolevulinic acid , 2000, International journal of cancer.

[23]  B. Jarvis,et al.  Topical Aminolevulinic Acid HCl Photodynamic Therapy , 2000, American journal of clinical dermatology.

[24]  Z. Halpern,et al.  [Photodynamic therapy for dysphagia due to esophageal carcinoma]. , 1999, Harefuah.

[25]  H. Barr,et al.  Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. , 1999, Journal of photochemistry and photobiology. B, Biology.

[26]  G. Stables,et al.  Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.

[27]  J. McEwan,et al.  Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty , 1999, The British journal of surgery.

[28]  T. Stephenson,et al.  5‐Aminolevulinic Acid Photosensitization of Dysplastic Barrett's Esophagus: A Pharmacokinetic Study , 1999, Photochemistry and photobiology.

[29]  Herbert Stepp,et al.  Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy , 1999, European Urology.

[30]  I. Stender,et al.  Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.

[31]  A. Berner,et al.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.

[32]  K Svanberg,et al.  Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. , 1999, Acta ophthalmologica Scandinavica.

[33]  M Korell,et al.  Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5‐aminolevulinic acid , 1999, International journal of cancer.

[34]  Robinson,et al.  Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.

[35]  K. Schomacker,et al.  Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.

[36]  Alison Curnow,et al.  Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.

[37]  J. Mühling,et al.  Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. , 1998, International journal of oral and maxillofacial surgery.

[38]  J. Moan,et al.  Kinetics of Photobleaching of Protoporphyrin IX in the Skin of Nude Mice Exposed to Different Fluence Rates of Red Light , 1998, Photochemistry and photobiology.

[39]  A. J. MacRobert,et al.  Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. , 1998, British Journal of Cancer.

[40]  H. Soyer,et al.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.

[41]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .

[42]  H Stepp,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. , 1998, The Journal of urology.

[43]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[44]  Joris Kloek,et al.  Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.

[45]  H Kerl,et al.  Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. , 1997, Journal of photochemistry and photobiology. B, Biology.

[46]  T. Ruzicka,et al.  Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses , 1997, Photodermatology, photoimmunology & photomedicine.

[47]  H Stepp,et al.  Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. , 1997, Journal of photochemistry and photobiology. B, Biology.

[48]  D. Ash,et al.  Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[49]  D. Kessel,et al.  Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.

[50]  H Stepp,et al.  Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[51]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[52]  P. Speight,et al.  Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.

[53]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[54]  Q. Peng,et al.  Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. , 1996, British Journal of Cancer.

[55]  G Hüttmann,et al.  Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. , 1996, Journal of photochemistry and photobiology. B, Biology.

[56]  P Baas,et al.  Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[57]  J Moan,et al.  Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.

[58]  R Baumgartner,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.

[59]  N. J. Brown,et al.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. , 1995, British Journal of Cancer.

[60]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[61]  A Gorchein,et al.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.

[62]  R Baumgartner,et al.  Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.

[63]  N. Brown,et al.  Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. , 1994, The Journal of urology.

[64]  R. Knüchel,et al.  [Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid]. , 1994, Der Urologe (Ausg. A).

[65]  Sharon Thomsen,et al.  PHOTODYNAMIC THERAPY WITH PHOTOFRIN II INDUCES PROGRAMMED CELL DEATH IN CARCINOMA CELL LINES , 1994, Photochemistry and photobiology.

[66]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[67]  D. Vernon,et al.  Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. , 1993, Journal of photochemistry and photobiology. B, Biology.

[68]  P. Speight,et al.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.

[69]  A. J. MacRobert,et al.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.

[70]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[71]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer Research.

[72]  S. G. Bown,et al.  Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. , 1992, British Journal of Cancer.

[73]  J. Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[74]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[75]  A Gorchein,et al.  Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms , 1992, European journal of clinical investigation.

[76]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[77]  M L Agarwal,et al.  Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.

[78]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[79]  J C Kennedy,et al.  Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.

[80]  M T Tseng,et al.  The effect of photodynamic therapy on the microcirculation. , 1988, The Journal of surgical research.

[81]  Z. Malik,et al.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.

[82]  H. Barr,et al.  THE CONTRASTING MECHANISMS OF COLONIC COLLAGEN DAMAGE BETWEEN PHOTODYNAMIC THERAPY and THERMAL INJURY , 1987, Photochemistry and photobiology.

[83]  J Moan,et al.  A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. , 1987, Cancer letters.

[84]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[85]  J C Kennedy,et al.  NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.

[86]  J Moan,et al.  Effect of bleaching of porphyrin sensitizers during photodynamic therapy. , 1986, Cancer letters.

[87]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[88]  J. Reynoldson,et al.  Neuropharmacology of delta-aminolaevulinic acid—I Effect of acute administration in rodents , 1984, Neuropharmacology.

[89]  T. Dougherty,et al.  Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.

[90]  J. Kennedy,et al.  Experimental Porphyric Neuropathy: A Preliminary Report , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[91]  Z. Malik,et al.  5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. , 1979, Cell differentiation.

[92]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[93]  S. Granick.  HEPATIC PORPHYRIA AND DRUG‐INDUCED OR CHEMICAL PORPHYRIA * , 1965, Annals of the New York Academy of Sciences.

[94]  D. Drabkin.  INTRODUCTION: SOME HISTORICAL HIGHLIGHTS IN KNOWLEDGE OF PORPHYRINS AND PORPHYRIAS , 1963 .

[95]  A. Neuberger,et al.  The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .

[96]  L. Guillou,et al.  Clinical assessment of fluorescence cystoscopy during transurethral bladder resection in superficial bladder cancer , 2004, Urological Research.

[97]  Michael Landthaler,et al.  Photodynamic therapy and fluorescence diagnosis of skin cancers. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[98]  M Korell,et al.  Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. , 1999, Obstetrics and gynecology.

[99]  W Roessler,et al.  5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. , 1999, Urology.

[100]  R. van Hillegersberg,et al.  Kinetics, localization, and mechanism of 5‐aminolevulinic acid‐induced porphyrin accumulation in normal and Barrett's‐like rat esophagus , 1999, Lasers in surgery and medicine.

[101]  N. J. Brown,et al.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. , 1997, British Journal of Cancer.

[102]  H. Kerl,et al.  Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. , 1997, Dermatology.

[103]  L. Braathen,et al.  Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.

[104]  J. Marriott.  Regulation of porphyrin synthesis. , 1968, Biochemical Society Symposium.

[105]  W. Star,et al.  In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.

[106]  L. Guillou,et al.  Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study , 1999, British Journal of Cancer.